May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular disease and, as a result, they are more likely to die or develop more serious ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
-
-
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone synthase inhibitor (ASI) for treating hypertension in combination with other ...
-
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American College of Cardiology’s Annual Scientific Session (ACC.26) that took place in March ...
-
May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on "Plaque-Informed Ischemia: A New Paradigm for Vessel-Specific Risk Assessment." The ...
May 28, 2026 — Coredio has announced that the U.S. Food and Drug Administration (FDA) has granted its Cardiac ...
May 28, 2026
May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular ...
May 26, 2026
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
May 21, 2026
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone ...
May 18, 2026
May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...
May 13, 2026
Feature | Heart Failure | Kyle Hardner
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...
May 13, 2026
May 12, 2026
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 11, 2026
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 07, 2026
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 07, 2026
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
May 07, 2026
Feature | Heart Failure | Kyle Hardner
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
May 04, 2026
Feature | FFR Technologies | Kyle Hardner
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 30, 2026
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
April 29, 2026
April 24, 2026 — University of Texas Health Science Center at Houston (UTHealth Houston) has established the Department ...
April 28, 2026